Snapzu Science
Monday 25 July 2016
First gene-editing trial to start next month in China
The immune cells of lung cancer patients at a hospital in Chengdu, China, are to be modified using the powerful CRISPR-Cas9 gene editing technology so they can target the tumour.
Continue reading...
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment